Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Treatment of Hyperphosphatemia Based on Phosphate Balance in Maintenance Hemodialysis Patients: a Multicenter, Randomized Clinical Trial

NCT03861247 is registered in ClinicalTrials.gov with Chen Jing as lead sponsor.

NCT NCT03861247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03861247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Treatment of Hyperphosphatemia Based on Phosphate Balance in Maintenance Hemodialysis Patients: a Multicenter, Randomized Clinical Trial
Lead sponsor
Chen Jing
Phase
Phase 3
Overall status
Completed
Start date
November 29, 2019
Completion date
April 15, 2021
Enrollment
123 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hyperphosphatemia, maintenance hemodialysis